posted on 2021-10-25, 10:30authored byPerry B Shieh, Gary Elfring, Panayiota Trifillis, Claudio Santos, Stuart W Peltz, Julie A Parsons, Susan Apkon, Basil T Darras, Craig Campbell, Craig M McDonald
Supplementary Table 1. Search strategy for Ovid MEDLINE® (1 January 2000 to 30 November 2020).
Supplementary Table 2. Search strategy for Ovid EMBASE® (1 January 2000 to 30 November 2020).
Supplementary Table 3. Primary and post-hoc studies of patients receiving deflazacort or prednisone/prednisolone.
Funding
This research was funded by PTC Therapeutics, Inc., and did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.